IMPACT OF OA

Osteoarthritis (OA) is a degenerative disease that affects more than 30 million Americans and accounts for more than $185 billion in annual expenditures.

Learn More

OUR PRODUCT

A non-opioid, extended-release, intra-articular injection that employs our proprietary microsphere technology to treat OA knee pain.

Read More

OUR SCIENCE

We are tireless in our pursuit of innovative science which holds the potential to transform the treatment of musculoskeletal conditions.

Learn More

OUR PIPELINE

Flexion’s strategy is to build a robust pipeline of locally administered therapies to address musculoskeletal conditions, with an initial focus on OA.

See the Pipeline

Join Our Team

Flexion Therapeutics prides itself on finding great talent, rewarding hard work and maintaining a culture that is unparalleled.

The Boston Globe Top Places to Work 2018

Learn More

Events


2019 AAOS

March 12-16, 2019
AAOS 2019 Annual Meeting
Las Vegas, NV

February 28, 2019 4:30 PM EST
Flexion Therapeutics Q4 2018 Earnings Call